Prevention of binding of rgp120 by anti-HIV active tannins
Several tannins with anti-HIV activity have been described previously (Nonaka et al., J Nat Prod 53: 587–595, 1990). We have shown that the tannins chebulinic acid and punicalin were able to block the binding of HIV rgpl20 to CD4. These compounds were not toxic to stimulated human peripheral blood l...
Gespeichert in:
| Veröffentlicht in: | Biochemical pharmacology 1992-06, Vol.43 (11), p.2479-2480 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2480 |
|---|---|
| container_issue | 11 |
| container_start_page | 2479 |
| container_title | Biochemical pharmacology |
| container_volume | 43 |
| creator | Weaver, James L. Pine, P.Scott Dutschman, Ginger Cheng, Yung-Chi Lee, Kuo-Hsing Aszalos, Adorjan |
| description | Several tannins with anti-HIV activity have been described previously (Nonaka
et al., J Nat Prod 53: 587–595, 1990). We have shown that the tannins chebulinic acid and punicalin were able to block the binding of HIV rgpl20 to CD4. These compounds were not toxic to stimulated human peripheral blood lymphocytes at concentrations ten times above their maximal effective concentration. |
| doi_str_mv | 10.1016/0006-2952(92)90328-G |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_16286975</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>000629529290328G</els_id><sourcerecordid>16286975</sourcerecordid><originalsourceid>FETCH-LOGICAL-c483t-b7f6ec8546b724ed38b33a6a41057e5afff137b86548e4aba94a3e434e7b3d263</originalsourceid><addsrcrecordid>eNp9kF1LwzAUhoMoc07_gUIvRPSimq-mqReCDN0GA71Qb0OSno7Ils6kG-zf29Ix74RAPt7nnBwehC4JvieYiAeMsUhpkdHbgt4VmFGZTo7QkMictc9CHqPhATlFZzF-d1cpyAANiCCYEzxEj-8BtuAbV_ukrhLjfOn8ojuGxZpQnJhdots4nc6-Em0bt4Wk0d47H8_RSaWXES72-wh9vr58jKfp_G0yGz_PU8sla1KTVwKszLgwOeVQMmkY00K332c5ZLqqKsJyI0XGJXBtdME1A8445IaVVLARuun7rkP9s4HYqJWLFpZL7aHeREUElaLIsxbkPWhDHWOASq2DW-mwUwSrTpnqBKjOhyra1SlTk7bsat9_Y1ZQ_hX1jtr8ep_raPWyCtpbFw9YllEmRDfmU49B62LrIKhoHXgLpQtgG1XW7v85fgFzG4V4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16286975</pqid></control><display><type>article</type><title>Prevention of binding of rgp120 by anti-HIV active tannins</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Weaver, James L. ; Pine, P.Scott ; Dutschman, Ginger ; Cheng, Yung-Chi ; Lee, Kuo-Hsing ; Aszalos, Adorjan</creator><creatorcontrib>Weaver, James L. ; Pine, P.Scott ; Dutschman, Ginger ; Cheng, Yung-Chi ; Lee, Kuo-Hsing ; Aszalos, Adorjan</creatorcontrib><description>Several tannins with anti-HIV activity have been described previously (Nonaka
et al., J Nat Prod 53: 587–595, 1990). We have shown that the tannins chebulinic acid and punicalin were able to block the binding of HIV rgpl20 to CD4. These compounds were not toxic to stimulated human peripheral blood lymphocytes at concentrations ten times above their maximal effective concentration.</description><identifier>ISSN: 0006-2952</identifier><identifier>EISSN: 1873-2968</identifier><identifier>DOI: 10.1016/0006-2952(92)90328-G</identifier><identifier>PMID: 1610410</identifier><identifier>CODEN: BCPCA6</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents ; antiviral activity ; Antiviral agents ; Antiviral Agents - pharmacology ; binding ; Biological and medical sciences ; CD4 antigen ; CD4 Antigens - metabolism ; Drug Design ; flow cytometry ; glycoprotein gp120 ; HIV Envelope Protein gp120 - metabolism ; human immunodeficiency virus ; Humans ; Lymphocytes - drug effects ; Lymphocytes - immunology ; Medical sciences ; Pharmacology. Drug treatments ; Protein Binding - drug effects ; Recombinant Proteins - metabolism ; tannins ; Tannins - pharmacology</subject><ispartof>Biochemical pharmacology, 1992-06, Vol.43 (11), p.2479-2480</ispartof><rights>1992</rights><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c483t-b7f6ec8546b724ed38b33a6a41057e5afff137b86548e4aba94a3e434e7b3d263</citedby><cites>FETCH-LOGICAL-c483t-b7f6ec8546b724ed38b33a6a41057e5afff137b86548e4aba94a3e434e7b3d263</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/000629529290328G$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=5523666$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1610410$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Weaver, James L.</creatorcontrib><creatorcontrib>Pine, P.Scott</creatorcontrib><creatorcontrib>Dutschman, Ginger</creatorcontrib><creatorcontrib>Cheng, Yung-Chi</creatorcontrib><creatorcontrib>Lee, Kuo-Hsing</creatorcontrib><creatorcontrib>Aszalos, Adorjan</creatorcontrib><title>Prevention of binding of rgp120 by anti-HIV active tannins</title><title>Biochemical pharmacology</title><addtitle>Biochem Pharmacol</addtitle><description>Several tannins with anti-HIV activity have been described previously (Nonaka
et al., J Nat Prod 53: 587–595, 1990). We have shown that the tannins chebulinic acid and punicalin were able to block the binding of HIV rgpl20 to CD4. These compounds were not toxic to stimulated human peripheral blood lymphocytes at concentrations ten times above their maximal effective concentration.</description><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>antiviral activity</subject><subject>Antiviral agents</subject><subject>Antiviral Agents - pharmacology</subject><subject>binding</subject><subject>Biological and medical sciences</subject><subject>CD4 antigen</subject><subject>CD4 Antigens - metabolism</subject><subject>Drug Design</subject><subject>flow cytometry</subject><subject>glycoprotein gp120</subject><subject>HIV Envelope Protein gp120 - metabolism</subject><subject>human immunodeficiency virus</subject><subject>Humans</subject><subject>Lymphocytes - drug effects</subject><subject>Lymphocytes - immunology</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Protein Binding - drug effects</subject><subject>Recombinant Proteins - metabolism</subject><subject>tannins</subject><subject>Tannins - pharmacology</subject><issn>0006-2952</issn><issn>1873-2968</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kF1LwzAUhoMoc07_gUIvRPSimq-mqReCDN0GA71Qb0OSno7Ils6kG-zf29Ix74RAPt7nnBwehC4JvieYiAeMsUhpkdHbgt4VmFGZTo7QkMictc9CHqPhATlFZzF-d1cpyAANiCCYEzxEj-8BtuAbV_ukrhLjfOn8ojuGxZpQnJhdots4nc6-Em0bt4Wk0d47H8_RSaWXES72-wh9vr58jKfp_G0yGz_PU8sla1KTVwKszLgwOeVQMmkY00K332c5ZLqqKsJyI0XGJXBtdME1A8445IaVVLARuun7rkP9s4HYqJWLFpZL7aHeREUElaLIsxbkPWhDHWOASq2DW-mwUwSrTpnqBKjOhyra1SlTk7bsat9_Y1ZQ_hX1jtr8ep_raPWyCtpbFw9YllEmRDfmU49B62LrIKhoHXgLpQtgG1XW7v85fgFzG4V4</recordid><startdate>19920609</startdate><enddate>19920609</enddate><creator>Weaver, James L.</creator><creator>Pine, P.Scott</creator><creator>Dutschman, Ginger</creator><creator>Cheng, Yung-Chi</creator><creator>Lee, Kuo-Hsing</creator><creator>Aszalos, Adorjan</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M81</scope><scope>P64</scope></search><sort><creationdate>19920609</creationdate><title>Prevention of binding of rgp120 by anti-HIV active tannins</title><author>Weaver, James L. ; Pine, P.Scott ; Dutschman, Ginger ; Cheng, Yung-Chi ; Lee, Kuo-Hsing ; Aszalos, Adorjan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c483t-b7f6ec8546b724ed38b33a6a41057e5afff137b86548e4aba94a3e434e7b3d263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>antiviral activity</topic><topic>Antiviral agents</topic><topic>Antiviral Agents - pharmacology</topic><topic>binding</topic><topic>Biological and medical sciences</topic><topic>CD4 antigen</topic><topic>CD4 Antigens - metabolism</topic><topic>Drug Design</topic><topic>flow cytometry</topic><topic>glycoprotein gp120</topic><topic>HIV Envelope Protein gp120 - metabolism</topic><topic>human immunodeficiency virus</topic><topic>Humans</topic><topic>Lymphocytes - drug effects</topic><topic>Lymphocytes - immunology</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Protein Binding - drug effects</topic><topic>Recombinant Proteins - metabolism</topic><topic>tannins</topic><topic>Tannins - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Weaver, James L.</creatorcontrib><creatorcontrib>Pine, P.Scott</creatorcontrib><creatorcontrib>Dutschman, Ginger</creatorcontrib><creatorcontrib>Cheng, Yung-Chi</creatorcontrib><creatorcontrib>Lee, Kuo-Hsing</creatorcontrib><creatorcontrib>Aszalos, Adorjan</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biochemistry Abstracts 3</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Biochemical pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Weaver, James L.</au><au>Pine, P.Scott</au><au>Dutschman, Ginger</au><au>Cheng, Yung-Chi</au><au>Lee, Kuo-Hsing</au><au>Aszalos, Adorjan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevention of binding of rgp120 by anti-HIV active tannins</atitle><jtitle>Biochemical pharmacology</jtitle><addtitle>Biochem Pharmacol</addtitle><date>1992-06-09</date><risdate>1992</risdate><volume>43</volume><issue>11</issue><spage>2479</spage><epage>2480</epage><pages>2479-2480</pages><issn>0006-2952</issn><eissn>1873-2968</eissn><coden>BCPCA6</coden><abstract>Several tannins with anti-HIV activity have been described previously (Nonaka
et al., J Nat Prod 53: 587–595, 1990). We have shown that the tannins chebulinic acid and punicalin were able to block the binding of HIV rgpl20 to CD4. These compounds were not toxic to stimulated human peripheral blood lymphocytes at concentrations ten times above their maximal effective concentration.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>1610410</pmid><doi>10.1016/0006-2952(92)90328-G</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0006-2952 |
| ispartof | Biochemical pharmacology, 1992-06, Vol.43 (11), p.2479-2480 |
| issn | 0006-2952 1873-2968 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_16286975 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Antibiotics. Antiinfectious agents. Antiparasitic agents antiviral activity Antiviral agents Antiviral Agents - pharmacology binding Biological and medical sciences CD4 antigen CD4 Antigens - metabolism Drug Design flow cytometry glycoprotein gp120 HIV Envelope Protein gp120 - metabolism human immunodeficiency virus Humans Lymphocytes - drug effects Lymphocytes - immunology Medical sciences Pharmacology. Drug treatments Protein Binding - drug effects Recombinant Proteins - metabolism tannins Tannins - pharmacology |
| title | Prevention of binding of rgp120 by anti-HIV active tannins |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T22%3A51%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevention%20of%20binding%20of%20rgp120%20by%20anti-HIV%20active%20tannins&rft.jtitle=Biochemical%20pharmacology&rft.au=Weaver,%20James%20L.&rft.date=1992-06-09&rft.volume=43&rft.issue=11&rft.spage=2479&rft.epage=2480&rft.pages=2479-2480&rft.issn=0006-2952&rft.eissn=1873-2968&rft.coden=BCPCA6&rft_id=info:doi/10.1016/0006-2952(92)90328-G&rft_dat=%3Cproquest_cross%3E16286975%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16286975&rft_id=info:pmid/1610410&rft_els_id=000629529290328G&rfr_iscdi=true |